Immupharma Share Discussion Threads

[top tips] 19/12/2017 12:09

bought some more. Nothing has changed.

[sportbilly1976] 19/12/2017 12:07

My immediate thought too - but think it is more volatility on thin volumes..

[hamila01] 19/12/2017 12:07

Or MM's playing games again?

[englishlongbow] 19/12/2017 12:05

Down 6p. Bad news?

[sportbilly1976] 19/12/2017 12:02

in auction??

[englishlongbow] 19/12/2017 11:57

Bayer recently offered $65 billion for Monsanto. Just shows how easy it would be to buyout IMM with that amount of cash around for acquisitions.

[hottingup] 19/12/2017 11:51

It should be fairly obvious by now that Lupuzor is more efficaceous and safer than Benlysta. Higher gross margin, cheaper sales price and applicability to multiple indications are also in Lupuzor's favour.

[uncleoswald] 19/12/2017 11:49

You can be my butler any day !:)

[andyr42] 19/12/2017 11:48

Best to you as well remarko for the festive season. No doubt we'll get back to our usual way in the new year and may it be a very happy and prosperous one for all. Take care on that BMX though :-)

[butler4] 19/12/2017 11:20

There is nothing to really report on IMM - its a waiting game until Jan/Feb - we all know what the consequences will be - if the results are positive, Happy Days - if they are negative we're all in the preverbial.

From our point of view as shareholders we just have to treat this as a business - hour to hour comments on the movement of the share price are meaningless - to us with limited pharma knowledge this share is a pure gamble although the signs are on the positive side

[hamhamham1] 19/12/2017 10:44

Be careful. You might get acc7sed of chart porn :)

[top tips] 19/12/2017 10:26

I hold a lot but not 25%. No need to be rude.

[gbh2] 19/12/2017 10:24

Too much drivel from newbies making this thread useless - Filtered the lot !

[professor bang bang] 19/12/2017 10:10

Improvement rates with Lupuzor

Phase 2b at 3 months = + 67.6%
Phase 2b at 6 months = + 84.2%
Phase 3 at 9 - 12 months = + 100% ??

For me its not now about whether lupuzor works but just how big the improvement will be at 9 and 12 months.

N.B.
Resetting the Autoreactive Immune System with a Therapeutic Peptide in Lupus
Prof. Sylvian Muller
Lupus (2015) 24, pg 412–418

"The phase IIb trial showed that after three months of therapy (three subcutaneous injections of 200 ug peptide/patient in addition to standard of care), Lupuzor improved Systemic Lupus Erythematosus Disease Activity Index score of lupus patients under active treatment by 67.6% versus 41.5% in the placebo group (p<0.025). After three additional months of follow-up, the improvement rate was 84.2% versus 45.8% (p<0.025). The side effect profile was unproblematic and the drug was well tolerated as evidenced by a very low drop-out rate."

www.lupuzor.com/Documents/Schall%20Muller%20Lupus%202015.pdf

[uncleoswald] 19/12/2017 09:59

It's nice to be nice!:)
Merry Christmas all

[andyr42] 19/12/2017 09:38

Having said all this, I am puzzled by you remarko & would like to meet you at some point. Perhaps in an AGM of IDP or IMM?

p.s. I am still in IDP in a big way. IDP will be £10+ 12-18 months. So few shares so many fantastic products and an entreprenaur with a difference. Can't go wrong at current price IMHO. Rate IMM slightly ahead though IDP a lot less risky. DYOR etc. and all that

[andyr42] 19/12/2017 09:30

Keep quiet these days until the time is right. Silence is golden.

p.s. we are wittnessing history in the making.